← Leaderboards
Ming-Chang Hu
Ut Southwestern Medical Center
$5,706,202
Attributed
$8,961,012
Total exposure
3
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.2M · FY2011–22$2M$1.5M$1M$500K$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$8,961,012 · 3
By mechanism
R01$8,961,012 · 3
Top collaborators
- Orson W Moe13 shared
- Naim M Maalouf4 shared
- Khashayar Sakhaee4 shared
- Makoto Kuro-O2 shared
Most similar at Ut Southwestern Medical Center
Same institution · by research overlap
- Jyothsna Gattineni$2,491,975
- Peiying Liu$6,913,428
- Priya Ravikumar$136,688
- Vivek R Sant$415,000
Others in their field
Top investigators on “Kidney”
- Jeffrey P Krischer · University Of South Florida$540,222,210
- John M Lachin · George Washington University$155,894,464
- David M Nathan · Massachusetts Institute Of Technology$127,229,266
- Kathryn Hirst · Caritas St. Elizabeth'S Medical Center$111,521,899
- David Heimbrook · Leidos Biomedical Research, Inc.$83,221,586
- Peter Scott Heeger · Case Western Reserve University$80,562,246
Research focus
KidneyBasePreventChronic Kidney FailureReceptorPre-ClinicalFunctional DisorderRodentCellsRodent ModelProteinsAnimalsIn VivoIn VitroPathogenesisDisease ProgressionImpairmentPreventionUp-RegulationAcute Renal Failure With Renal Papillary NecrosisRecoveryAcuteReperfusion TherapyMortality Vital Statistics
Grant awards (24)
Pathogenesis of Uric Acid Nephrolithiasis$510,253
R01 · FY2022 · DK
Pathogenesis of Uric Acid Nephrolithiasis$508,607
R01 · FY2021 · DK
Klotho and Phosphate in Chronic Kidney Disease: Pathogenesis and Therapeutics$364,500
R01 · FY2021 · DK
Klotho: Therapeutic Agent for Ischemia Reperfusion Induced Acute Kidney Injury$364,500
R01 · FY2021 · DK · contact PI
Pathogenesis of Uric Acid Nephrolithiasis$505,438
R01 · FY2020 · DK
Klotho: Therapeutic Agent for Ischemia Reperfusion Induced Acute Kidney Injury$364,500
R01 · FY2020 · DK · contact PI
Klotho and Phosphate in Chronic Kidney Disease: Pathogenesis and Therapeutics$364,500
R01 · FY2020 · DK
Pathogenesis of Uric Acid Nephrolithiasis$500,648
R01 · FY2019 · DK
Klotho and Phosphate in Chronic Kidney Disease: Pathogenesis and Therapeutics$364,500
R01 · FY2019 · DK
Klotho: Therapeutic Agent for Ischemia Reperfusion Induced Acute Kidney Injury$364,500
R01 · FY2019 · DK · contact PI
Klotho: Therapeutic Agent for Ischemia Reperfusion Induced Acute Kidney Injury$364,500
R01 · FY2018 · DK · contact PI
Klotho and Phosphate in Chronic Kidney Disease: Pathogenesis and Therapeutics$364,500
R01 · FY2018 · DK
Klotho: Therapeutic Agent for Ischemia Reperfusion Induced Acute Kidney Injury$364,500
R01 · FY2017 · DK · contact PI
Klotho and FGF23 in Chronic Kidney Disease: Pathogenesis and Theraputics$345,825
R01 · FY2015 · DK
Klotho: Therapeutic Agent for Ischemia Reperfusion Induced Acute Kidney Injury$345,825
R01 · FY2015 · DK · contact PI
Klotho: Therapeutic Agent for Ischemia Reperfusion Induced Acute Kidney Injury$121,125
R01 · FY2015 · DK · contact PI
Klotho and FGF23 in Chronic Kidney Disease: Pathogenesis and Theraputics$345,825
R01 · FY2014 · DK
Klotho: Therapeutic Agent for Ischemia Reperfusion Induced Acute Kidney Injury$345,825
R01 · FY2014 · DK · contact PI
Klotho: Therapeutic Agent for Ischemia Reperfusion Induced Acute Kidney Injury$333,722
R01 · FY2013 · DK · contact PI
Klotho and FGF23 in Chronic Kidney Disease: Pathogenesis and Theraputics$333,722
R01 · FY2013 · DK
Klotho: Therapeutic Agent for Ischemia Reperfusion Induced Acute Kidney Injury$345,825
R01 · FY2012 · DK · contact PI
Klotho and FGF23 in Chronic Kidney Disease: Pathogenesis and Theraputics$345,372
R01 · FY2012 · DK
Klotho and FGF23 in Chronic Kidney Disease: Pathogenesis and Theraputics$396,250
R01 · FY2011 · DK
Klotho: Therapeutic Agent for Ischemia Reperfusion Induced Acute Kidney Injury$396,250
R01 · FY2011 · DK · contact PI